← Back to Search

Cannabinoid

Cannabidiol for Chronic Pain

Phase < 1
Waitlist Available
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 days
Awards & highlights

Study Summary

This trial will investigate whether CBD can help relieve chronic pain.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Neurochemical Brain Changes
Secondary outcome measures
Pain Improvement

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: CannabidiolActive Control1 Intervention
Drug: Cannabidiol An oral dose of Cannabidiol (CBD) will be given once a day for five day with pain ratings taken before and after each dose every day. Other Names: CBD
Group II: PlaceboPlacebo Group1 Intervention
Drug: Placebos An oral placebo will be given once a day for five day with pain ratings taken before and after each dose every day. Other Names: placebo

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,098 Previous Clinical Trials
1,778,578 Total Patients Enrolled
27 Trials studying Chronic Pain
4,481 Patients Enrolled for Chronic Pain

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria do applicants need to meet in order to be selected for this research?

"In order to be considered, prospective participants must meet certain standards: aged between 18-50 years old with chronic musculoskeletal and joint pain persisting for at least 3 months; as well as residing within a 60 mile radius of Salt Lake City, Utah. In total, the trial is seeking 52 individuals who fit this criteria."

Answered by AI

What other research endeavors have been conducted concerning Cannabidiol?

"Presently, there are 79 ongoing studies that focus on Cannabidiol with 16 of them being at the third stage. A majority of these trials are conducted in Ribeirao Preto and Sao Paulo but other 290 sites have been identified as potential locations for such experiments too."

Answered by AI

Are any volunteers being admitted to this investigation at present?

"According to clinicaltrials.gov, this ongoing medical trial is currently looking for participants. It initially went public on March 16th 2020 and was most recently updated in March 8th 2022."

Answered by AI

Does this experiment take into account the needs of septuagenarians?

"The eligibility parameters for this study necessitate that the patient have to be at least 18 and no older than 50."

Answered by AI

What is the approximate number of people contributing to this research endeavor?

"Affirmative. Per information available on clinicaltrials.gov, this study is currently recruiting candidates that meet the criteria for inclusion. Originally posted in March 2020, it was most recently updated in early March 2022 and seeks 52 participants at one location."

Answered by AI

Who else is applying?

What state do they live in?
Utah
How old are they?
18 - 65
What site did they apply to?
University Of Utah
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Mechanisms of CBD for Chronic Pain
Deborah Yurgelun-Todd 2020. "Mechanisms of CBD for Chronic Pain". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04044729.
All > American Chronic Pain > Epidiolex
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top